×
About 2,898 results

ALLMedicine™ Allergic Conjunctivitis Center

Research & Reviews  457 results

Interleukin-33-activated neuropeptide CGRP-producing memory Th2 cells cooperate with so...
https://doi.org/10.1016/j.immuni.2022.09.016
Immunity Okano M, Hirahara K et. al.

Oct 23rd, 2022 - Allergic conjunctivitis is a chronic inflammatory disease that is characterized by severe itch in the conjunctiva, but how neuro-immune interactions shape the pathogenesis of severe itch remains unclear. We identified a subset of memory-type patho...

Ocular Biodistribution of Once-Daily 0.6% Bilastine Eye Drops Reveals Highest Levels in...
https://doi.org/10.1089/jop.2022.0024
Journal of Ocular Pharmacology and Therapeutics : the Off... Torrens I, Ganza Á et. al.

Oct 22nd, 2022 - Purpose: Bilastine is a second-generation antihistamine that has been shown to be effective for treatment of allergic conjunctivitis. The objective of this study was to evaluate the pharmacokinetics (PKs) and biodistribution of 0.6% bilastine pres...

Efficacy of Proactive Topical Antihistamine Use in Patients with Seasonal Allergic Conj...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618478
Advances in Therapy; Fukushima A, Miyazaki D et. al.

Oct 17th, 2022 - Topical antihistamines are often instilled symptomatically to control patients' eye allergy symptoms. The purpose of this study was to evaluate the effectiveness of proactive and as-needed use of antihistamine eye drops in controlling symptoms and...

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT05579730

Oct 14th, 2022 - To evaluate the efficacy of Combo (Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution) compared to its individual components and vehicle in a population of subjects with allergic conjunctivitis:

Effectiveness of hyaluronic acid and arnica extract ophthalmic solution in reducing dry...
https://doi.org/10.1177/11206721221128670
European Journal of Ophthalmology; Buzzonetti L, Petroni S et. al.

Oct 4th, 2022 - to assess the effectiveness of a new combination of topical solution with Hyaluronic Acid 0.2% and arnica extract 0.1% in reducing dry eye symptoms in a population of pediatric patients. 52 pediatric patients (aged 9 to 14 years) with signs and sy...

see more →

Drugs  521 results see all →

Clinicaltrials.gov  120 results

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT05579730

Oct 14th, 2022 - To evaluate the efficacy of Combo (Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution) compared to its individual components and vehicle in a population of subjects with allergic conjunctivitis:

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT05314621

Sep 2nd, 2022 - At Visit 1, subjects will sign the informed consent and an allergic skin test will be performed, if required. Each qualifying subject will undergo a bilateral conjunctival allergen challenge (Ora-CAC®) titration using an allergen they had a positi...

The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT05234554

May 10th, 2022 - The INVIGORATE 2 Trial: A single-center, randomized, double-masked, crossover design, vehicle-controlled, Phase 3 clinical trial to assess the efficacy and safety of reproxalap ophthalmic solution (0.25%) compared to vehicle in subjects with seaso...

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis
https://clinicaltrials.gov/ct2/show/NCT05265910

May 3rd, 2022 - This is a single-center, randomized, double-masked, parallel study. In this clinical study, the efficacy comparison between Pataday® Once Daily Relief Extra Strength and Claritin® Tablets 24-Hour will be made using the Ora-CAC model, a validated c...

Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
https://clinicaltrials.gov/ct2/show/NCT04622345

Apr 27th, 2022 - The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of allergic conjunctivitis using an antigen challenge model

see more →

News  55 results

Dupilumab-Associated Ocular Surface Disease in Patients With AD: Unravelling the Link
https://www.medscape.com/viewarticle/982857

Oct 21st, 2022 - MONTREAL — Ocular surface disease (OSD) in patients with atopic dermatitis (AD) treated with dupilumab may be exacerbated rather than caused by the therapy, according to a study presented at the annual meeting of the International Society of Atopi...

Immunotherapy for Allergic Rhinitis and Asthma Has Lasting Effects
https://www.medscape.com/viewarticle/982447

Oct 13th, 2022 - Allergen immunotherapy (AIT) for allergic rhinitis and asthma is effective long-term, according to a literature review of real-world evidence by researchers in Germany and Poland. "Real-world data for AIT complement those from randomized controlle...

Study Links Poor Physical Fitness to Children's Eye Allergies
https://www.medscape.com/viewarticle/981884

Oct 4th, 2022 - CHICAGO, Illinois — Children who are more physically fit seem to be less prone to eye allergies, according to a study of more than 1 million 10-year-olds in Taiwan that was reported at the annual meeting of the American Academy of Ophthalmology (A...

New Nasal Spray Approved for Nasal and Ocular Seasonal Allergic Rhinitis
https://www.medscape.com/viewarticle/980360

Sep 7th, 2022 - Patients with both nasal and ocular symptoms of seasonal allergic rhinitis (SAR) have a new treatment option that combines olopatadine hydrochloride and mometasone furoate in the form of a nasal spray. Ryaltris (Hikma Pharmaceuticals PLC and Glenm...

Unilateral eye irritation
https://www.mdedge.com/familymedicine/article/254196/unilateral-eye-irritation
MDedge Family Medicine;

Apr 28th, 2022 - Physical examination revealed an irregularly shaped conjunctival cyst on the lateral (temporal) field of the right eye. (This diagnosis is usually made based on the clinical examination alone.

see more →

Patient Education  6 results see all →